| 1 | Energy | XLE | +26.3% |
| 2 | Technology | XLK | +18.7% |
| 3 | Industrials | XLI | +15.5% |
| 4 | Real Estate | XLRE | +14.3% |
| 5 | Materials | XLB | +13.5% |
| 6 | Consumer Staples | XLP | +12.1% |
| 7 | Healthcare | XLV | +7.7% |
| 8 | Utilities | XLU | +5.8% |
| 9 | Financials | XLF | +4.7% |
| 10 | Consumer Disc. | XLY | -5.2% |
| 11 | Communication | XLC | -6.3% |
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 7/29/26 | $-0.95 | — | — | — | $0.2B | — | — | — |
| Q1 '26 | 4/29/26 | $-0.80 | $-0.30 | +62.5% | +68% | $0.2B | $0.2B | +26.2% | +86% |
| Q4 '25 | 2/25/26 | $-1.26 | $-1.15 | +8.7% | -167% | $0.2B | $0.2B | +30.2% | -11% |
| Q3 '25 | 10/29/25 | $-1.12 | $-0.61 | +45.3% | +15% | $0.1B | $0.2B | +20.5% | +17% |
| Q2 '25 | 7/30/25 | $0.16 | $0.85 | +4.3% | +454% | $0.3B | $0.5B | +57.1% | +101% |
| Q1 '25 | 4/30/25 | $-1.03 | $-0.93 | +9.7% | -21% | $0.1B | $0.1B | +7.8% | +11% |